Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations

[1]  F. Schumacher,et al.  Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells , 2019, Epigenetics.

[2]  P. Oefner,et al.  D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization , 2018, Oncoimmunology.

[3]  R. Souza,et al.  Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer , 2018, Proceedings of the National Academy of Sciences.

[4]  J. Costello,et al.  Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas , 2017, The Journal of clinical investigation.

[5]  Arthur James Cooper,et al.  The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites , 2017, Biology.

[6]  Gregory A. Breuer,et al.  2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity , 2017, Science Translational Medicine.

[7]  Amar Deep Sharma,et al.  Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo , 2017, Leukemia.

[8]  A. Unterberg,et al.  Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo , 2017, Acta Neuropathologica.

[9]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[10]  J. Engh,et al.  IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. , 2016, Neuro-oncology.

[11]  K. Dettmer,et al.  Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique , 2016, Front. Oncol..

[12]  Paul P Jung,et al.  Saccharomyces cerevisiae Forms d-2-Hydroxyglutarate and Couples Its Degradation to d-Lactate Formation via a Cytosolic Transhydrogenase*♦ , 2016, The Journal of Biological Chemistry.

[13]  Kevin Cho,et al.  Evidence that 2-hydroxyglutarate is not readily metabolized in colorectal carcinoma cells , 2015, Cancer & Metabolism.

[14]  Sejong Bae,et al.  A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody , 2014 .

[15]  Aubry K. Miller,et al.  D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma , 2014, Acta neuropathologica communications.

[16]  E. Christensen,et al.  Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing , 2013, Journal of Medical Genetics.

[17]  W. Kaelin,et al.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. , 2013, Genes & development.

[18]  O. Abdel-Wahab,et al.  The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization* , 2012, The Journal of Biological Chemistry.

[19]  N. Demaurex,et al.  The renaissance of mitochondrial pH , 2012, The Journal of general physiology.

[20]  R. Verhaak,et al.  Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation , 2012, Nature.

[21]  R. Klose,et al.  The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.

[22]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[23]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[24]  E. Holme,et al.  IDH2 Mutations in Patients with d-2-Hydroxyglutaric Aciduria , 2010, Science.

[25]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[26]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[27]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[28]  M. Knaap,et al.  Development and implementation of a novel assay for l-2-hydroxyglutarate dehydrogenase (l-2-HGDH) in cell lysates: l-2-HGDH deficiency in 15 patients with l-2-hydroxyglutaric aciduria , 2009, Journal of Inherited Metabolic Disease.

[29]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[30]  U. Flügge,et al.  Two d-2-Hydroxy-acid Dehydrogenases in Arabidopsis thaliana with Catalytic Capacities to Participate in the Last Reactions of the Methylglyoxal and β-Oxidation Pathways* , 2009, The Journal of Biological Chemistry.

[31]  K. Gibson,et al.  Measurement of d-2-hydroxyglutarate dehydrogenase activity in cell homogenates derived from d-2-hydroxyglutaric aciduria patients , 2009, Journal of Inherited Metabolic Disease.

[32]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[33]  M. Aghili,et al.  Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review , 2008, Journal of Neuro-Oncology.

[34]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[35]  R. Rzem,et al.  The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. , 2006, Biochimie.

[36]  W. Craigen,et al.  Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. , 2005, American journal of human genetics.

[37]  D. Vertommen,et al.  Identification of a dehydrogenase acting on D-2-hydroxyglutarate. , 2004, The Biochemical journal.

[38]  Gregg Pratt,et al.  DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration , 1998 .

[39]  K. Gibson,et al.  Stable-Isotope Dilution Analysis of D- and L-2-Hydroxyglutaric Acid: Application to the Detection and Prenatal Diagnosis of D- and L-2-Hydroxyglutaric Acidemias , 1993, Pediatric Research.

[40]  D. Levin,et al.  Isolation and characterization of a hydroxyacid-oxoacid transhydrogenase from rat kidney mitochondria. , 1988, The Journal of biological chemistry.